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Abstract
Background
The Fremantle Back Awareness Questionnaire (FreBAQ) claims to assess disrupted self-
perception of the back. The aim of this study was to develop a German version of the Fre-
BAQ (FreBAQ-G) and assess its test-retest reliability, its known-groups validity and its con-
vergent validity with another purported measure of back perception.
Methods
The FreBaQ-G was translated following international guidelines for the transcultural adapta-
tion of questionnaires. Thirty-five patients with non-specific CLBP and 48 healthy partici-
pants were recruited. Assessor one administered the FreBAQ-G to each patient with CLBP
on two separate days to quantify intra-observer reliability. Assessor two administered the
FreBaQ-G to each patient on day 1. The scores were compared to those obtained by asses-
sor one on day 1 to assess inter-observer reliability. Known-groups validity was quantified
by comparing the FreBAQ-G score between patients and healthy controls. To assess con-
vergent validity, patient’s FreBAQ-G scores were correlated to their two-point discrimination
(TPD) scores.
Results
Intra- and Inter-observer reliability were both moderate with ICC3.1 = 0.88 (95%CI: 0.77
to 0.94) and 0.89 (95%CI: 0.79 to 0.94), respectively. Intra- and inter-observer limits of
agreement (LoA) were 6.2 (95%CI: 5.0–8.1) and 6.0 (4.8–7.8), respectively. The adjusted
mean difference between patients and controls was 5.4 (95%CI: 3.0 to 7.8, p<0.01).
Patient’s FreBAQ-G scores were not associated with TPD thresholds (Pearson’s r = -0.05,
p = 0.79).
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Conclusions
The FreBAQ-G demonstrated a degree of reliability and known-groups validity. Interpreta-
tion of patient level data should be performed with caution because the LoA were substan-
tial. It did not demonstrate convergent validity against TPD. Floor effects of some items of
the FreBAQ-G may have influenced the validity and reliability results. The clinimetric proper-
ties of the FreBAQ-G require further investigation as a simple measure of disrupted self-per-
ception of the back before firm recommendations on its use can be made.
Introduction
Low back pain is a major cause of disability worldwide [1] and is associated with substantial
health care costs [2]. Many interventions attempt to normalise assumed peripheral structural
pathology [3]. However, current treatment strategies provide limited and short-term pain
relief [4].
The cortical body representation is distorted in people with persistent pain which may play
an important role in the development and/or maintenance of pain [5]. Early work by Flor et al
[6] using brain imaging identified somatosensory disorganization in patients with chronic low
back pain (CLBP). More recent imaging studies in people with CLBP have shown structural
and functional alterations in cortical and subcortical areas, associated with the processing of
sensory information [7–9].
These changes can present clinically as alterations in a person’s body perception [10–13],
decreased ability to distinguish/interpret peripheral sensory stimuli [14–16] and impaired
lumbopelvic motor control [17]. Interventions targeting these perceptual distortions may pres-
ent novel approaches to managing persistent low back pain [18–23]. Due to the growing
research and clinical interest in cortical body representation, there is an increasing need for
valid and reliable body perception measurement tools which are quick and easy to deliver clin-
ically. A recent systematic review highlighted the lack of such measures and the need for fur-
ther work in this area [24]
The Freemantle Back Awareness Questionnaire (FreBAQ) is a simple tool that claims to
assess back-specific altered body perception [25]. It comprises 9 items with a five-point Likert
scale attempting to investigate neglect-associated features, proprioceptive acuity, and a per-
son’s perceived body image [26, 27].
In people with CLBP, the FreBAQ has been associated with a number of clinical characteris-
tics such as pain duration (Pearson correlation ρ = 0.357, p = 0.01) and pain intensity (Spear-
man’s rho = 0.40, p = 0.004) [26] though others have found no such relationship [28]. As a
measure of body perception it has demonstrated evidence for known-groups validity (median
difference between healthy controls and people with CLBP = 11, Mann-Whitney test, p<
0.001) and reliability (ICC2,1agreement = 0.652 (95% CI: 0.307 to 0.848),ICC2,1consistency = 0.667
(95% CI: 0.317 to 0.857) [26] but did not provide evidence of convergent validity with other
body perception measures in a different pain population [29]. The FreBAQ was recently trans-
lated and validated into Japanese (FreBAQ-J) [27] and Dutch [28]. However, a German ver-
sion does not yet exist within the peer-reviewed literature.
The aim of this study was to produce a German version of the FreBAQ (FreBAQ-G) and
assess its test-retest reliability, its known-groups validity and its convergent validity as a mea-
sure of disrupted self-perception of the back.
The German Fremantle Back Awareness Questionnaire
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Methods
Translation and face validity
The FreBAQ translation was conducted following international guidelines for the transcultural
adaptation of self-reported measures [30]. This process attempts to maintain content validity
by ensuring that similar issues are covered, taking into consideration language differences and
potentially differing sociocultural backgrounds [31].
Firstly, two native German speakers translated the original English FreBAQ independently
of each other into German. One translator (K.E.) was a physiotherapist and researcher well
acquainted with the subject area and one was a university graduated translator and occupational
therapist but uninformed regarding the subject area (M.D.). Consensus regarding discrepancies
was reached through discussion between both translators. Secondly, the revised German version
was back-translated into English by two different translators, neither of whom had any specialist
knowledge in the subject area of physiotherapy or chronic pain; one (J.J.H.) was a university lec-
turer in psychology and a native English speaker fluent in German while the other (A.J.) was a
German English teacher, fluent in English. Again, consensus was reached regarding differences
in wording through discussion between translators. Thirdly, the whole translation process was
documented by K.E. and discussed with the developer of the original English version (B.W.)
arriving at a pre-final German version (FreBAQ-G) (AppendixS1).
Once this translation process was complete, the FreBAQ-G was provided to a group of indi-
viduals with CLBP and healthy controls to assess its face validity. Face validity can be defined
as “the degree to which a measurement instrument, looks as though it is an adequate reflection
of the construct to be measured”[32]. As there are currently no standards concerning its mea-
surement or quantification [33], three major aspects were assessed; completeness of content,
comprehensibility and time to complete. Both groups provided feedback on completeness of
content (“Do you think that this questionnaire covers the most important aspects of altered
back related perception? [Yes/No]”; “If “NO” which aspects would you incorporate?”), com-
prehensibility (“Are the questions sufficiently comprehensibly worded? [Yes/No]”; “If “No”
which items are not sufficiently comprehensible?”) and time to complete (“Is the time needed
for filling in the questionnaire appropriate?) scored on a 0–10 scale with 0 representing “unac-
ceptably long” and 10 “completely ok”). These questions were deemed to provide information
on overall usability and whether it potentially needed revision due to content or linguistic
ambiguities [28].
Floor and ceiling effects of the questionnaire were investigated in the CLBP group on an
item level and by assessment of the total scores. Ceiling and floor effects occur when a consid-
erable proportion of subjects score highest or lowest on a scale, demonstrating the measure
unsuitable to discriminate between subjects at either extreme of the scale [34, 35]. Ceiling or
floor effects were considered present if more than 15% of respondents achieved the highest or
lowest possible score, respectively [36].
Participants
35 patients with non-specific CLBP were recruited consecutively from physiotherapy practices
in Bochum, Germany between June 2013 and December 2014. Participants had to meet the
following inclusion criteria: age18 years; non-specific CLBP with or without leg pain (for
those with leg pain, the back pain had to be dominant); duration of symptoms6 months; suf-
ficient cognitive and German language ability to understand both oral and written instruc-
tions, provide feedback and informed consent. Participants were excluded if they were
pregnant or less than 6 months post-partum, had signs and symptoms indicating serious spinal
The German Fremantle Back Awareness Questionnaire
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pathologies (i.e. red flags), thus differentiating them clinically from people with non-specific
CLBP [37].
In addition, a sample of 48 healthy participants, recruited from staff and students (lower
age limit: 18 years) at the University of Applied Health Sciences in Bochum, Germany were
recruited. According to the original FreBAQ protocol by Wand et al [26] healthy participants
had to meet the following criteria: currently back pain free, no episode of back pain within the
last two years restricting them from work or leisure activities, sufficient cognitive and German
language ability to understand both oral and written instructions, provide feedback and
informed consent. Exclusion criteria were pregnancy or less than 6 months post-partum or
significant spinal deformities. The study was approved by Teesside University’s School of
Health and Social Care Research Governance and Ethics Board (Study No 186/12) and the
Ethics committee of the German National Physiotherapists Society (Ethics committee submis-
sion number: 2013–02). Before study commencement, all participants provided written
informed consent to participate in the study.
The patient population provided basic demographic data and clinical characteristics as well
as a battery of outcome measures recommended for back pain research, including measures of
symptom severity and frequency, physical function, general well-being and current work dis-
ability [38]. Demographic information comprised: age, sex, height, weight, body mass index
(BMI), and current working status. Clinical characteristics comprised: duration of symptoms,
FreBAQ-G, Brief Pain Inventory Short form (BPI) [39], (pain intensity and interference);
Roland Morris Disability Questionnaire (RMDQ) [40] (function); Hospital Anxiety and
Depression Scale (HADS) [40] (anxiety and depression) and Euroquol 5D-3L [41] (quality-of-
life).
The control group provided the same basic demographic data and also completed the
HADS and the FreBAQ-G. Regarding the FreBAQ-G instructions the wording was slightly
adopted in that the phrase “other patients” was replaced by “other people” and the section con-
cerning current pain experience was replaced by “please indicate to which degree your back
feels like this”.
Within the data analysis a FreBAQ-G item which was not answered was categorised as ‘not
endorsed’, in keeping with Wand et al [26] and scored as zero, representing “never feels like
this”. All analyses were conducted using SPSS, version 24 (IBM, Armok, USA) or Microsoft
Excel 2010, version 14 (Microsoft, Redmond, USA).
Relationship to clinical status
To quantify the association between the FreBAQ-G and the clinical characteristics of the
patients a series of Pearson’s or Spearman’s correlations were conducted dependent upon the
normality of the data. An r value of 0.10, 0.30 and 0.5 represented small, medium and large
correlations respectively [42]. We hypothesised that people scoring higher on the FreBAQ-G,
indicating a more disturbed self-perception of the back, would achieve poorer scores on other
clinical outcome measures, assessing different constructs, such as pain and physical function.
Reliability
One assessor (KE) provided the FreBAQ-G to each participant with CLBP on two separate
days. The participants were asked to complete the questionnaire independently in the presence
of the assessor in a quiet room of the University’s outpatient department. The assessor did not
provide any assistance with the completion of the questionnaire. Day 1 and day 2 were on
average one week apart. FreBAQ-G scores between day 1 and day 2 (collected by assessor 1),
were compared to quantify intra-observer reliability over one week. To quantify inter-observer
The German Fremantle Back Awareness Questionnaire
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reliability, a second assessor provided the questionnaire to each participant on day 1 approxi-
mately two hours after it was provided by KE, and this was compared to the scores obtained by
the first assessor’s administration on day 1. Assessors were blind to previous FreBAQ-G scores,
as the questionnaires were immediately filed in a folder and only analysed upon the partici-
pant’s completion of the study. On day 2, the participant was not provided with any informa-
tion regarding their previous scores to reduce the risk of recall bias.
The data obtained by assessor one on day one was used to quantify the frequencies of
responses per item. The systematic bias (mean (95% CI) between data collected from two
assessors on the same day and from one assessor from two sessions was determined using a
paired t-test. Within-subjects standard deviations, defined as the standard error of measure-
ment, coefficients of variation, limits of agreement and a random-error only intraclass correla-
tion coefficient (ICC), model 3.1, were calculated to quantify the random error component
within and between assessors.
The within-subjects SD was then used within a statistical power calculation to estimate
whether the random measurement error identified in this study was small enough to detect a
clinically relevant change in FreBAQ scores with a feasible sample size. As no MCID for the
FreBAQ exists a value of 10 was chosen as the MCID within the power calculation based upon
previous data quantifying the difference in FreBAQ between people with back pain and
healthy controls [26]. ICC3.1 scores of<0.75 were considered to demonstrate poor reliability,
0.75–0.89 moderate and0.90 excellent reliability [43]. Statistical significance was set at
p0.05 [44].
Validity
Internal consistency. Internal consistency of the FreBAQ-G was assessed by calculating
the Cronbach’s alpha coefficient. A correlation coefficient of at least 0.7 was defined as indica-
tive of adequate inter-relatedness of items [33].
Convergent validity. Convergent validity is defined as a positive correlation between
instruments assuming to measure the same underlying construct [33]. To assess the conver-
gent validity the patient’s FreBAQ-G scores were correlated to their two-point discrimination
(TPD) scores measured by assessor one on day 1. TPD is a simple clinical test of tactile acuity
which measures the minimum distance between two points on the skin that can be obviously
detected with smaller distances indicating better acuity [45]. It has been shown to be a valid
measure of cortical reorganization when compared against the gold standard measure of fMRI
[46] and other clinical tests which purport to measure body awareness indirectly such as move-
ment control tests [47]. The TPD collection method and data have been published previously
[48]. The measurement tool was a two-point discrimination caliper (Nexgen Medical Systems,
Florida,USA) with a 1 mm precision. To minimise the risk of assessor bias assessor 1 was not
aware of the FreBAQ results when undertaking the TPD assessment. In principal, we hypothe-
sised a positive correlation between FreBAQ total scores and TPD results. The direction of this
hypothesis was based on findings from previous studies, demonstrating an association between
an altered body image and tactile acuity, measured by TPD [14, 16, 23].
Known-groups validity. Known-groups validity is defined as an instrument’s ability to
differentiate between individuals with a specific condition and healthy individuals [33] or its
ability to differentiate between two groups on a construct on which they theoretically should
differ [49]. To investigate the known-groups validity of the FreBAQ-G the total score on the
questionnaire was compared between the group of patients and healthy controls. There was no
attempt to match groups regarding characteristics such as age and sex, which may affect body
perception. However, when assessing the difference between groups an ANCOVA was used
The German Fremantle Back Awareness Questionnaire
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which adjusted for age, sex and BMI. We hypothesised that people with CLBP would differ
from healthy controls on the construct of self-perception of the back, as assessed by the Fre-
BAQ-G, in that healthy people would on average score lower compared to people with CLBP,
demonstrating better self-perception of the back in healthy controls.
Results
Translation and face validity
The majority of participants in both groups found the FreBAQ-G to be a complete and com-
prehensible measure, which could be completed within an appropriate period of time
(Table 1).
In the patient group, additional questions about content covering aspects of night sleep,
stair climbing, current awareness of posture, morning stiffness and current sensory abnormali-
ties hampering body awareness were suggested for inclusion. Regarding comprehensibility it
was stated by one patient that the double negative expressions in question 4, 5, and 6 could be
misleading. With respect to questions 2 and 3 one individual suggested to provide examples of
which specific activities were meant.
Given the qualitative feedback, and as all three scores of the feedback form were well below
the preset threshold of 50% negative responses, it was judged that the translation process
revealed no obvious cultural adaptations necessary for a German speaking population.
Participant characteristics and questionnaire responses
The participant characteristics for each group are shown in Table 2. On average the control
group was 16 years younger and there were small differences in sex and BMI between groups.
Thus age, sex and BMI were adjusted for as covariates in the comparison between groups.
For the patient group, pain severity at time 1 and 2, were 3.6 and 3.5 respectively, defined as
mild severity [50]. The average back related physical function was 7.5 at time 1, defined as a
mild-to-moderate functional impairment [51]. In addition, both groups had similar HADS
anxiety scores (mean (SD) CLBP group: 5.2 (3.4), control group: 4.8 (2.2)), both of which
could be interpreted as normal [52].
Of the 35 participants with CLBP, two did not answer item 2 at timepoint one, one did not
answer item 8 at timepoint one and two and one participant did not answer item 7 at time-
point two. In all, missing items account for 1.6% of the data, thus it is unlikely that they had a
significant impact on the overall results.
The frequencies of FreBAQ-G responses, as well as the mean and median scores for the
patient group are displayed per item in Table 3. All nine items were at least endorsed at some
level, although reported frequencies differed across items. Items 2 and 9 were the most often
endorsed. In contrast, items 6, 7 and 8 were the most infrequently endorsed, with more than
Table 1. Results of feedback form.
Item CLBP group (n = 35) Control group (n = 48)
1 Completeness of Contents N (%) 25 (71.4) 39 (81.3)
2 Comprehensibility N (%) 29 (82.9) 37 (77.1)
3 Appropriateness of time to complete
Mean (SD)
(0–10 scoring system)
9.9 (0.8) 9.9 (0.2)
N = proportion of participants stating complete agreement or acceptance with item; CLBP = chronic low back pain
https://doi.org/10.1371/journal.pone.0205244.t001
The German Fremantle Back Awareness Questionnaire
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80% of participants stating that their back never feels shrunk (item 8). In contrast, items 3, 4, 5
and 6 were not endorsed on the upper end of the Likert scale (‘always feels like this’).
Relationship to clinical status
The associations between the FreBAQ-G and the clinical characteristics in the patient group
were moderate for all characteristics except for duration of symptoms, which was unrelated to
the FreBAQ-G (see Table 4).
Reliability
Intra-observer reliability. The mean value for the FreBAQ-G scores obtained from the
participants by assessor 1 on day 1 was 8.8 (SD 6.1) and 7.8 (SD 7.0) on day 2. The mean Fre-
BAQ-G difference score within one week for assessor 1 was 1.06 (95% CI: -0.03 to 2.14,
p = 0.055). The ICC3.1 values for absolute agreement and consistency were 0.88 (95%CI: 0.77
to 0.94) and 0.89 (95%CI: 0.79 to 0.94), respectively. The Bland and Altman plot for the indi-
vidual differences between day 1 and 2 for assessor 1 is shown in Fig 1.
Table 2. Descriptive statistics of study sample.
CLBP patients (n = 35)
Mean (SDa) or N (%)
Healthy Controls (n = 48)
Mean (SD) or N (%)
p-values
Study sample demographic information
Gender (female) 23 (65.8%) 30 (62.5%) p = 0.76
Age (years) 52 (15.2) 36 (17.5) p<0.01
Height (cm) 172 (9.9) 173 (8.3) p = 0.66
Weight (kg) 76 (17.1) 69 (11.8) p = 0.16
BMI 25.3 (4.9) 23.1 (2.6) p = 0.09
Work Status
Employed or student 20 (54.3%) 43 (89.6%)
Retired (age related) 12 (34.3%) 5 (10.4%)
Certified sick due to back pain 3 (8.6%) 0 (0%)
Certified sick due to other reasons 1 (2.9%) 0 (0%)
Clinical Status
Symptom Duration (years) 11 (11)
BPI T1:
Pain Severity 3.6 (2.0)
Pain Interference 2.6 (2.0)
BPI T2:
Pain Severity 3.5 (1.9)
Pain Interference 2.1 (1.8)
RMDQ 7.5 (4.6)
HADS:
Anxiety 5.2 (3.4) 4.8 (2.2) p = 0.08
Depression 4.5 (3.1) 2.3 (1.9) p<0.01
EuroQuol:
VAS (%) 65 (21)
Index Value 0.81 (0.20)
SD = Standard Deviation, BMI = Body Mass index, BPI = Brief Pain Inventory, T1 = Session 1, T2 = Session 2, RMDQ = Roland Morris Disability Questionnaire,
HADS = Hospital Anxiety and Depression Scale; EuroQuol = Euroquol 5D-3L; VAS = Visual analogue scale; bold figures indicate statistical significance on 0.05 level.
https://doi.org/10.1371/journal.pone.0205244.t002
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Inter-observer reliability. The mean value for the FreBAQ-G scores obtained from the
participants by assessor 1 and 2 on day 1 was 8.8 (SD 6.1) and 7.4 (SD 7.2) respectively. The
mean FreBAQ-G difference score on the same day between assessors 1 and 2 was 1.4 (95% CI:
0.36 to 2.45, p = 0.01).The ICC3.1 values for absolute agreement and consistency were 0.88
(95%CI: 0.75 to 0.94) and 0.90 (95%CI: 0.81 to 0.95), respectively. The Bland and Altman plot
for the individual differences between assessor 1 and 2 is shown in Fig 2.
Table 3. Frequency of responses to each FreBAQ-G item in the patient group (n = 35).
Item Response category Never feels
like that
Rarely feels
like that
Occasionally or some of
the time feels like that
Often, or a moderate
amount of time feels
like that
Always, or most of
the time feels like
that
Median Mean
Scoring 0 1 2 3 4
Frequency of Responses N (%) N (%) N (%) N (%) N (%)
1 My back feels as though it is not part
of the rest
of my body
19 (54.3) 6 (17.1) 4 (11.4) 5 (14.3) 1 (2.9) 0 0.9
2 I need to focus all my attention on
my back to make it move the way I
want it to
7 (20.0) 9 (25.7) 8 (22.9) 9 (25.7) 2 (5.7) 2 1.6
3 I feel as if my back sometimes moves
involuntarily, without my control
15 (42.9) 10 (28.6) 8 (22.9) 2 (5.7) 0 (0) 1 0.9
4 When performing everyday tasks, I
don’t know how my back is moving
13 (37.1) 11 (31.4) 8 (22.9) 3 (8.6) 0 (0) 1 1.0
5 I am not sure exactly what position
my back is in
15 (42.9) 9 (25.7) 8 (22.9) 3 (8.6) 0 (0) 1 1.0
6 I can’t perceive the exact outline of
my back
20 (57.1) 7 (20.0) 5 (14.3) 3 (8.6) 0 (0) 0 0.7
7 My back feels like it is enlarged
(swollen)
23 (65.7) 1 (2.9) 7 (20.0) 3 (8.6) 1 (2.9) 0 0.8
8 My back feels like it has shrunk 28 (80.0) 3 (8.6) 2 (5.7) 1 (2.9) 1 (2.9) 0 0.3
9 My back feels lopsided
(asymmetrical)
12 (34.3) 5 (14.3) 6 (17.1) 7 (20.0) 5 (14.3) 2 1.7
N = absolute frequency responses, FreBAQ-G = Fremantle Back Awareness Questionnaire German
https://doi.org/10.1371/journal.pone.0205244.t003
Table 4. Univariate correlations between FreBAQ-G total scores and clinical characteristics in the patient popula-
tion (n = 35).
Correlation p-value
Anxiety (HADS-A)a 0.37 0.03
Depression (HADS-D)b 0.52 <0.001
Duration of Symptoms (Years) b 0.06 0.72
Pain severity (BPI) a 0.32 0.07
Pain interference (BPI)b 0.47 <0.001
Back related disability (RMDQb 0.46 <0.001
HADS-A = Hospital Anxiety and Depression Scale- Anxiety; HADS-D = Hospital Anxiety and Depression Scale-
Depression; BPI = Brief Pain Inventory; RMDQ = Roland-Morris-Disability Questionnaire.
 Correlation is significant at the 0.05 level (2-tailed).
aPearson correlation coefficient.
bSpearman correlation coefficient.
https://doi.org/10.1371/journal.pone.0205244.t004
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The systematic bias for inter- and intra-observer reliability in both cases equaled approxi-
mately one unit on the 0–36 FreBAQ-G scale. All data quantifying the systematic and random
error components of the reliability analysis are displayed in Table 5.
Fig 1. Limits of agreement for intra-observer reliability. For intra-observer reliability, the FreBAQ-G difference
scores for assessor 1 at day 1 and 2 are plotted against their mean scores. Mean session differences (systematic bias) are
displayed by solid lines and limits of agreement by dashed lines.
https://doi.org/10.1371/journal.pone.0205244.g001
Fig 2. Limits of agreement for inter-observer reliability. For inter-observer reliability, the FreBAQ-G difference
scores for assessor 1 and 2 are plotted against their mean scores. Mean session differences (systematic bias) are
displayed by solid lines and limits of agreement by dashed lines.
https://doi.org/10.1371/journal.pone.0205244.g002
The German Fremantle Back Awareness Questionnaire
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Validity
Internal consistency. A Cronbach’s alpha value of 0.91 indicated an adequate internal
consistency of all items of the German version of the FreBAQ in people with chronic low back
pain. Table 6 displays Cronbach’s Alpha values, given that one out of nine items was deleted,
as well as inter-item correlations and total-item correlations.
Moreover, the internal consistency score was not severely affected by deletion of one item
and correlations greater 0.7 were found between each item and the total score except for item
7 (r = 0.57), item 8 (r = 0.43) and item 9 (0.66).
Known-groups validity. The FreBAQ-G total scores in the patient group ranged from
0–21, the mean score (SD) was 8.8 (6.1) and the median score 7.0. In the control group, the
total FreBAQ-G score ranged from 0–13, the mean score (SD) was 4.0 (3.3) and the median
score was 3.0. FreBAQ-G scores were, on average, higher in the CLBP group compared to the
control group [unadjusted mean difference (95%CI) 4.8 (2.55 to 7.15), p<0.01].
There was a statistically significant effect between groups regarding the FreBAQ-G scores
after adjusting for age, gender and BMI (F (1.78) = 20.39, p<0.001, adjusted R2 = 0.22). The
adjusted mean scores for the patient group was 9.1 (95%CI: 7.77 to 10.87) and 3.7 (95%CI:
2.31 to 5.18) for the control group with an adjusted mean difference of 5.4 (95%CI: 3.02 to
7.79, p<0.01).
Table 5. Intra–and Inter-observer reliability data.
Intra-observer Inter-observer
Mean session difference 1.06 (-0.03–2.14) 1.40 (0.36–2.44)
SD of session differences 3.15 (2.55–4.13) 3.04 (2.46–3.98)
Within-subjects SD (SEM) 2.23 (1.80–2.92) 2.15 (1.74–2.82)
Coefficient of variation (%) 26.86 (21.71–35.16) 26.45 (21.39–34.65)
Limits of agreement (LOA) 6.18 (-5.12–7.24) 5.96 (-4.56–7.36)
ICC3.1 absolute agreement (95%CI) 0.88 (0.75–0.94) 0.90 (0.79–0.94)
SD = Standard Deviation; SEM = Standard Error of Measurement; CI = Confidence Interval, ICC3.1 = Intraclass
Correlation coefficient (absolute agreement). Ninety-five percent confidence intervals are presented in brackets for
all metrics.
https://doi.org/10.1371/journal.pone.0205244.t005
Table 6. Internal consistency of the German Fremantle back awareness questionnaire in people with chronic low back pain.
FreBAQ-G item Cronbach’s Alpha if item deleted Item-total Correlation Inter-Item Correlation matrix
Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9
Item 1 0.90 0.74 0.66 0.53 0.59 0.67 0.72 0.47 0.30 0.52
Item 2 0.90 0.71 0.66 0.75 0.60 0.64 0.64 0.47 0.15 0.42
Item 3 0.90 0.76 0.53 0.75 0.64 0.68 0.75 0.45 0.38 0.45
Item 4 0.90 0.73 0.59 0.60 0.64 0.70 0.64 0.47 0.27 0.52
Item 5 0.89 0.84 0.67 0.64 0.68 0.70 0.77 0.45 0.62 0.59
Item 6 0.89 0.81 0.72 0.64 0.75 0.64 0.77 0.42 0.52 0.54
Item 7 0.91 0.57 0.47 0.47 0.45 0.47 0.45 0.42 0.08 0.63
Item 8 0.91 0.43 0.30 0.15 0.38 0.27 0.62 0.52 0.08 0.38
Item 9 0.90 0.66 0.52 0.42 0.45 0.52 0.59 0.54 0.63 0.38
FreBAQ-G = Fremantle Back Awareness Questionnaire-German version
https://doi.org/10.1371/journal.pone.0205244.t006
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Convergent validity. The total FreBAQ scores were not associated with the mean TPD
thresholds (Spearman’s rho = -0.05, p = 0.79) in the patient group (see Fig 3).
Discussion
Participants found the FreBAQ-G demonstrated completeness of contents, comprehensibility
and could be completed within an acceptable amount of time. These findings are in line with
the results of the cross-cultural adaptation of the Dutch version of the FreBAQ-Q [28], in
which participants (n = 22) with CLBP reported an overall acceptable comprehensibility of
77% and an acceptable level of completeness of contents of 82%. Quantitatively, the mean
score of 8.8 for the patients on the FreBAQ-G, was similar to those reported for the original
English version (10.8) [26] and the Dutch version (11) [28]. This adds confidence to the trans-
lation process and cross-cultural validity of the FreBAQ-G. Three out of 35 participants in the
patient group scored 0 in total, equaling 9% of the total scores. This was below our predefined
criteria of 15%, suggesting that floor/ceiling effects were not an issue for the questionnaire as a
total score. However, from the frequency of responses per item potential floor effects of the
FreBAQ-G could be deduced while there was no evidence of ceiling effects. These item specific
floor effects could have artificially enhanced the level of reliability and whilst have a detrimen-
tal effect on the validity of the FreBAQ-G reported in this study.
The FreBAQ-G demonstrated adequate internal consistency, with a Cronbach’s alpha of
0.91 being slightly higher compared to other translated versions [27, 28]. However, as our sam-
ple size was smaller than those of the other validation studies, these results need to be inter-
preted cautiously.
The FreBAQ-G showed moderate intra and inter-observer reliability with ICC3.1 values of
0.88. These values were similar (or higher) to those reported for the Japanese [27] (ICC3,1 of
0.81 (95% CI: 0.67–0.89)), Dutch [28] (ICC2.1 = 0.69 (95%CI: (0.51–0.82)) and original English
Fig 3. Scatterplot of the total FreBAQ-G score plotted against the mean TPD thresholds for the patient group.
https://doi.org/10.1371/journal.pone.0205244.g003
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version [26] (ICC2.1 = 0.65 (95% CI: 0.307–0.848)). A systematic bias of one unit between time
1 and 2 for observer 1 indicated some small learning effects, thus a familiarization session may
be warranted when using this questionnaire.
The SEM (intra- and inter-observer) in our study was ~2units, below the SEM of 3.5
reported by Janssens et al [28]. However, with 95% limits of agreement ~6units, this indicates
an individual patient with CLBP could change by as much as 6units due to normal variation.
In addition, a random error component of ~26% (CV) suggests the FreBAQ-G may be more
appropriately used on a group level rather than an individual patient level.
To understand if the FreBAQ-G has sufficient reliability for research purposes it can be use-
ful to use the estimated variability of the measure and its minimally clinically important differ-
ence (MCID) to calculate sample sizes for different study designs. There is no existing
empirically derived MCID for the FreBAQ. Using 0.5 of a standard deviation as a clinically
worthwhile change one could estimate an MCID of approximately 3.0 units for power calcula-
tion purposes. Assuming the SD of change is 3.15 (see Table 5) it can be estimated that n = 14
would be required for a single arm pre-post study (two-tailed significance level< 0.05, statisti-
cal power = 90%) to detect the difference between a null hypothesis mean of 0.0 and an alterna-
tive mean of 3.0 units. Within an RCT design, under the same conditions, a sample size of
n = 25 in each arm would be required. Both estimated sample sizes could be considered achiev-
able within a musculoskeletal research context, supporting the potential of the FreBAQ in
research.
The convergent validity of the FreBAQ-G was assessed by correlating it with TPD. There
was no correlation between the FreBAQ-G and the TPD, in contrast to our initial hypothesis.
These results were in keeping with Wand et al [29] who found no correlation between the
English version of the FreBAQ and TPD in a sample of 34 pregnant women. This questions
the assumption whether both assessments measure the same construct, although previous
studies have demonstrated a relationship between body image drawings and tactile acuity in
patients with CLBP [13, 14]. However, outlining or drawing one’s perceived body image and
answering dedicated questions regarding one’s perceived body awareness might require differ-
ent cognitive and self-reflective skills. Moreover, TPD testing constitutes a direct measurement
requiring touch. Hence, TPD could be seen as a test to investigate peripheral innervation den-
sity and/or intact neural sensory pathways rather than a person’s perceived body image [53].
Body perception as measured by the FreBAQ-G was correlated with a number of the clini-
cal outcomes assessed. This implies that the FreBAQ-G may have clinical utility and body per-
ception may be a clinically relevant construct in this patient population. In our study sample,
disturbed body perception was associated with pain interference scores (BPI-I), but not with
symptom duration. In addition, FreBAQ-G scores showed moderate correlations to back
related disability (RMDQ) and anxiety and depression scores (HADS). It may be possible that
an altered self-perception of the back, in particular motor neglect aspects, might contribute to
motor control impairments, resulting in higher back related disability scores [54, 55]. In addi-
tion, a growing body of evidence supports the notion that anxiety and depression negatively
affect an individual’s confidence in an adequate loading of the back and might hence contrib-
ute to the distortion of the self-perception of the back [56, 57].
Our findings are partly in line with both English study samples, where statistically signifi-
cant correlations to pain severity were found (Pearson’s r = 0.40, p = 0.04)[26] and (Pearson’s
r = 0.27, p<0.001) [25]. The strength of the relationship between the FreBAQ-G and pain
severity in our sample was similar to those studies (r = 0.32, p = 0.07). In addition, the Japanese
sample [27] showed only correlations to back pain intensity in motion whereas the Dutch sam-
ple did not demonstrate any correlations to pain intensity at all [28]. Differences between our
findings and those of other studies may due to differences in methodology. The differences
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here could be attributable to the greater anxiety and depression scores in our study sample
compared to the Japanese study and that our sample showed higher values in pain scores inter-
fering with daily function (BPI-pain interference scores) in contrast to the pain intensity in
motion scores in the Japanese sample. However, all existing versions of the FreBAQ showed a
correlation between back related disability and disturbed body perception [26–28]. This could
be explained by the fact that an inability to adequately perform activities of daily living might
be associated with reduced sensorimotor lumbopelvic control [17, 55].
In contrast to Wand et al [26] and Nishigami et al [27], our sample showed an association
between anxiety and depression scores and disturbed body perception. This finding may be
attributable to the notion that cognitive emotional aspects of pain drive central nervous adap-
tation, such as central sensitization, which may in turn modulate sensorimotor control and
body perception [58].
The FreBAQ-G demonstrated a degree of known-groups validity, identifying a difference
of ~5units between individuals with CLBP and health participants, after adjusting for age, gen-
der and BMI. The difference between groups was half that previously reported (11.0 units)
using the original FreBAQ [26]. This difference may have been due to sample differences in
both the clinical and control participants between that study and our study.
Strengths and limitations
Regarding the translation process, an initial pre-testing phase in a smaller sample of patients
with CLBP could have been utilized to reveal and resolve any difficulties regarding compre-
hensibility and completeness of contents before commencing the study. However, patients
were satisfied with all usability aspects. In addition, we did not measure the exact amount of
time it took patients to complete the questionnaire though participants reported that the time
to complete was appropriate in their opinion. The current version of the FreBAQ-G demon-
strated evidence of floor effects on an item level. This might have adversely affected reliability
and validity scores. However, regarding sum scores, the percentage of respondents scoring 0
were below the pre-defined cut-off value of 15%. Hence, our main criterion demonstrated that
floor effects did not appear to be an issue in our sample.
Although all the patient participants in our study were patients accessing a health care set-
ting for treatment of their CLBP they were on the low end of the spectrum for the range of clin-
ical measures that were used, especially regarding anxiety and depression scores. Thus, our
findings may not be generalisable to the wider CLBP population, especially those scoring
higher on the clinical spectrum.
Our final sample size of 35 patients was lower than current recommendations of 40 partici-
pants or more for reliability studies [59]. Initially, 51 individuals were contacted. Ten people
did not respond to any further communication and six did not meet the inclusion criteria. In
addition, for the known-groups validity testing, the design would have been improved if
groups were matched on key characteristics such as age, sex and BMI, however these were
adjusted for statistically in the analysis.
To assess the convergent validity of the FreBAQ-G, its scores were correlated to TPD per-
formance which claims to measure the same/or similar construct. The choice of comparator
measure to assess convergent validity was difficult as there is no gold standard measure for the
construct of self-perception of the back. A recent systematic review published by our group
[24] found there were no existing measures of sensory motor perception that have demon-
strated adequate levels of validity and reliability. However, the review did identify TPD as one
of the most promising measures. In addition, TPD is one of the most commonly used mea-
sures of back perception within the literature [60–62] and it has been previously used as
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comparator for other measures of sensorimotor back function [17]. Thus it was chosen as the
comparator in this study but the findings should be interpreted cautiously. Finally, while com-
ponents of the validity of the FreBAQ-G have been assessed, definitive evidence that the Fre-
BAQ-G measures the construct back self-perception is lacking. This is likely attributable to the
fact that self-perception is a complex construct to define and, as previously stated, no definitive
gold standard measure exists. Further exploration of the validity of the FreBAQ-G is
warranted.
Clinical implications
The translation and assessment of the German FreBAQ is an important step in the use of this
questionnaire in people with CLBP, as is makes it available to a German speaking population
of 118 million people [63]. The FreBAQ-G constitutes a time efficient, low-cost and safe assess-
ment tool, provisionally demonstrating acceptable levels of reliability for research purposes
though it is unclear if the level of reliability is sufficient to be used at the individual patient
level. There is evidence of small learning effects, thus a familiarisation session would appear
warranted.
The FreBAQ-G is not proposed as an alternative outcome measure to established clinical
measures such as pain and function. However, if a researcher/clinician wishes to assess the spe-
cific construct of self-perception of the back very few instruments are available and the clini-
metric properties of those measures are limited [24]. If self-perception of the back is a
construct of interest the FreBAQ-G could be a potentially useful tool. However, it should be
employed knowing that the current level of validity is unclear and its level of reliability is not
yet sufficient to be used on an individual patient level. Further research is required before firm
recommendations on the use of the FreBAQ-G can be made.
Conclusion
Main results
We created a German translation of the FreBAQ. The FreBAQ-G demonstrated a degree of
reliability and known-groups validity, while it did not demonstrate convergent validity against
a measure, which purports to assess the same construct. These findings are broadly in keeping
with other language versions of the questionnaire. The clinimetric properties of the FreBAQ-G
require further investigation as a simple measure of self-perception of the back.
Practical tips
Given the degree of measurement error the FreBAQ-G could potentially be employed for
research purposes to assess back self-perception but it may be too variable to monitor change
in individual patients. To minimize learning effects, a familiarisation trial should be consid-
ered. The validity of the FreBAQ-G requires further exploration.
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